Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 7/20 | 0.44 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.43 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.43 |
| ▸ | F10 | P00742 | 6/20 | 0.42 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 6/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 6/20 | 0.42 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7314871 | 0.92 | HTR1A (0.44) | SIGMAR1ITGB3ITGA2BF10 | |
| SCHEMBL7314991 | 0.92 | ADRA2A (0.42) | SIGMAR1ITGB3ITGA2BF10PRSS1 | |
| SCHEMBL6600250 | 0.91 | ITGB3 (0.48) | SIGMAR1ITGB3ITGA2BF10PRSS1 | |
| SCHEMBL7313240 | 0.91 | ITGB3 (0.48) | SIGMAR1ITGB3ITGA2BF10PRSS1 | |
| SCHEMBL7304344 | 0.91 | ITGB3 (0.48) | SIGMAR1ITGB3ITGA2BF10PRSS1 | |
| SCHEMBL7314580 | 0.89 | ALDH1A1 (0.47) | SIGMAR1ITGB3ITGA2BF10PRSS1 | |
| SCHEMBL6601675 | 0.89 | ITGB3 (0.54) | SIGMAR1ITGB3ITGA2BF10PRSS1 | |
| SCHEMBL6603444 | 0.89 | ITGB3 (0.54) | SIGMAR1ITGB3ITGA2BF10PRSS1 | |
| SCHEMBL6600851 | 0.89 | ITGB3 (0.54) | SIGMAR1ITGB3ITGA2BF10PRSS1 | |
| SCHEMBL7317590 | 0.89 | SIGMAR1 (0.46) | SIGMAR1ITGB3ITGA2BF10PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6455529-B1 | OXAZOLIDIN-2-ONE DERIVATIVES; ANTICOAGULANTS; ANTIMETASTASIS, ANTICARCINOGENIC, ANTIISCHEMIC, AND ANTIINFLAMMATORY AGENTS; OSTEOPOROSIS, ARTERIOSCLEROSIS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2002-09-24 | — | — | US | disclosed |
| EP-0741133-A2 | Adhesion receptor antagonists | MERCK PATENT GmbH (DE) | 1996-11-06 | — | — | EP | disclosed |